Metabolically Healthy Obesity, Transition to Unhealthy Phenotypes, and Type 2 Diabetes in 0.5 Million Chinese Adults: the China Kadoorie Biobank

Overview

Journal Eur J Endocrinol

Publisher Oxford University Press

Specialty Endocrinology

Date 2021 Dec 7

PMID 34874895

Citations 10

Authors

Zimin Song

Meng Gao

Jun Lv

Canqing Yu

Yu Guo

Zheng Bian

Yuxia Wei

Ling Yang

Huaidong Du

Yiping Chen

Jianqiang Zhang

Jvying Yao

Junshi Chen

Zhengming Chen

Tao Huang

Liming Li

Affiliations

Soon will be listed here.

Abstract

Objectives: To prospectively assess the association of metabolic health status and its transition with incident diabetes risk across BMI categories.

Design: Cohort study based on the China Kadoorie Biobank (CKB).

Methods: The CKB study enrolled 512 715 adults aged 30-79 years from ten diverse areas in China during 2004-2008. After exclusion, 432 763 participants were cross-classified by BMI categories and the metabolic status was followed up for incident diabetes disease. The changes in BMI and metabolic health status were defined from baseline to the second resurvey.

Results: Type 2 diabetes risk is higher for metabolically healthy obese (MHO) subjects than metabolically healthy normal weight (MHN) individuals (HR: 3.97, 95% CI: 3.64-3.66), and it is highest for those affected by metabolically unhealthy obese (MUO) (HR: 6.47, 95% CI: 6.17-6.79). About 15.26% of participants with MHN converted to metabolically healthy overweight or obesity (MHOO), whereas 48.40% of MHOO remained unconverted throughout the follow-up. In obese or overweight people, the conversion from metabolically healthy to unhealthy might increase the chances of developing diabetes as compared to those with a stable metabolic healthy state (HR: 3.70, 95% CI: 2.99-4.59), while those with persistent metabolic disorders are most likely to have diabetes (HR: 8.32, 95% CI: 7.08-9.78).

Conclusions: Metabolic healthy is a transient state, and individuals converted from metabolically healthy status to unhealthy phenotypes across all BMI categories might raise the risk of diabetes.

Citing Articles

Classification and identification of risk factors for type 2 diabetes.

Tang S, Zhao X, An X, Sun W, Kang X, Sun Y World J Diabetes. 2025; 16(2):100371.

PMID: 39959280 PMC: 11718467. DOI: 10.4239/wjd.v16.i2.100371.

Diabetes in China: epidemiology, pathophysiology and multi-omics.

Jia W, Chan J, Wong T, Fisher E Nat Metab. 2025; 7(1):16-34.

PMID: 39809974 DOI: 10.1038/s42255-024-01190-w.

Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China.

Lin Z, Si S, Liu J, Zhu H, Xu J, Artime E Front Endocrinol (Lausanne). 2024; 15:1470394.

PMID: 39574954 PMC: 11578730. DOI: 10.3389/fendo.2024.1470394.

Association between major dietary patterns and obesity phenotypes in southwest China: baseline survey results from Hechuan.

Shaomei W, Dezhi J, Mengfen L, Huaan D, Xianbin D, Juan P Front Nutr. 2024; 11:1467025.

PMID: 39568722 PMC: 11577167. DOI: 10.3389/fnut.2024.1467025.

Relationship between metabolically healthy overweight/obesity and risk of type 2 diabetes in different ethnicity: a prospective cohort study in southwest China.

Wang X, Wu Y, Wang Y, Zhou J, Liu T BMC Public Health. 2024; 24(1):2798.

PMID: 39396945 PMC: 11472488. DOI: 10.1186/s12889-024-20254-w.

References

Phillips C . Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2016; 1391(1):85-100. DOI: 10.1111/nyas.13230. View

Navarro-Gonzalez D, Sanchez-Inigo L, Fernandez-Montero A, Pastrana-Delgado J, Martinez J . Are all metabolically healthy individuals with obesity at the same risk of diabetes onset?. Obesity (Silver Spring). 2016; 24(12):2615-2623. DOI: 10.1002/oby.21667. View

Stefan N, Schick F, Haring H . Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017; 26(2):292-300. DOI: 10.1016/j.cmet.2017.07.008. View

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

Stefan N, Haring H, Hu F, Schulze M . Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2014; 1(2):152-62. DOI: 10.1016/S2213-8587(13)70062-7. View

Bell J, Hamer M, Sabia S, Singh-Manoux A, Batty G, Kivimaki M . The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015; 65(1):101-102. DOI: 10.1016/j.jacc.2014.09.077. View

Appleton S, Seaborn C, Visvanathan R, Hill C, Gill T, Taylor A . Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013; 36(8):2388-94. PMC: 3714523. DOI: 10.2337/dc12-1971. View

Zhang M, Tong W, Chen J, Zhang Y, Li S . Metabolically healthy obesity and its associates in Mongolian Chinese adults. Metab Syndr Relat Disord. 2014; 12(3):185-90. PMC: 4275772. DOI: 10.1089/met.2013.0102. View

Razak F, Anand S, Shannon H, Vuksan V, Davis B, Jacobs R . Defining obesity cut points in a multiethnic population. Circulation. 2007; 115(16):2111-8. DOI: 10.1161/CIRCULATIONAHA.106.635011. View

10.

Caleyachetty R, Neil Thomas G, Toulis K, Mohammed N, Gokhale K, Balachandran K . Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women. J Am Coll Cardiol. 2017; 70(12):1429-1437. DOI: 10.1016/j.jacc.2017.07.763. View

11.

Lotta L, Gulati P, Day F, Payne F, Ongen H, van de Bunt M . Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 2016; 49(1):17-26. PMC: 5774584. DOI: 10.1038/ng.3714. View

12.

Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L . Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J. 2021; 42(34):3374-3384. PMC: 8423468. DOI: 10.1093/eurheartj/ehab413. View

13.

Hu F . Diet and exercise for new-onset type 2 diabetes?. Lancet. 2011; 378(9786):101-2. DOI: 10.1016/S0140-6736(11)60692-2. View

14.

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

15.

Luo D, Liu F, Li X, Yin D, Lin Z, Liu H . Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine. 2014; 49(1):130-8. DOI: 10.1007/s12020-014-0444-2. View

16.

Plummer M . Improved estimates of floating absolute risk. Stat Med. 2003; 23(1):93-104. DOI: 10.1002/sim.1485. View

17.

Gao M, Lv J, Yu C, Guo Y, Bian Z, Yang R . Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study. PLoS Med. 2020; 17(10):e1003351. PMC: 7598496. DOI: 10.1371/journal.pmed.1003351. View

18.

Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y . Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol. 2005; 34(6):1243-9. DOI: 10.1093/ije/dyi174. View

19.

Bell J, Kivimaki M, Hamer M . Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014; 15(6):504-15. PMC: 4309497. DOI: 10.1111/obr.12157. View

20.

Lyall D, Celis-Morales C, Ward J, Iliodromiti S, Anderson J, Gill J . Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study. JAMA Cardiol. 2017; 2(8):882-889. PMC: 5710596. DOI: 10.1001/jamacardio.2016.5804. View